Hemovigilance is a systematic process of monitoring and evaluating the safety and efficacy of blood transfusions and blood products to prevent adverse reactions and improve patient outcomes. It encompasses the entire transfusion chain, from donor selection to the follow-up of recipients, ensuring the highest standards of blood safety and quality.

Hemovigilance

monitoring and evaluating the safety and efficacy of blood transfusions

blood transfusions

blood products

Adverse reactions are unintended and harmful responses to a medication or treatment, which can range from mild side effects to severe and life-threatening conditions. Understanding and monitoring these reactions are crucial for patient safety and effective healthcare management.

adverse reactions

Patient outcomes refer to the end results of healthcare practices and interventions, reflecting the impact on the health status, quality of life, and satisfaction of patients. Improving patient outcomes is a primary goal in healthcare, requiring a focus on evidence-based practices, patient-centered care, and continuous quality improvement.

patient outcomes

transfusion chain

Donor selection is a critical process in blood donation and transplantation that ensures the safety and compatibility of donor blood or organs with recipients. It involves rigorous screening and testing to prevent the transmission of infectious diseases and to ensure the donor's health and suitability for donation.

CUSTOMIZE YOUR LEARNING

CUSTOMIZE YOUR LEARNING